(607) 227-8695info@prendismo.com

Ted Hagelin Shares Reevaluation of Cases When Research Tools Are Seen As Assays Instead of Drugs

Copyright © Cornell University Play All Videos in Case

Total Case Duration :

  • Date Added : 10/26/2005
  • Clip Duration : 2 min. 59 sec.

Playlists

Please Login to create playlists

Ted Hagelin

  • Professor, Syracuse University
  • male
  • Caucasian
  • 1943 (Age: 81 years old)
  • Ted Hagelin - What Every Researcher Should Know About Patent Law - RPI Biotechnology Management & Entrepreneurship Seminar Series
  • Video 1 of 26 in this Case
  • View All Available Videos

Biography

Professor Hagelin teaches intellectual property and technology commercialization law at Syracuse University School of Law. His research focuses on intellectual property strategy and patent valuation. He has developed a new method to value patents, called Competitive Advantage Valuation or CAV, and currently has a patent application pending on the CAV method.

Professor Hagelin is the founder and director of the Syracuse University New Technology Law Center (SUNTEC) and of the Technology Commercialization Research Center (TCRC). In his capacity as director of the TCRC, Professor Hagelin has supervised over 75 research projects on the commercial development of early-stage technologies on behalf of universities, federal research laboratories, technology development organizations, and large, medium, small and start-up companies.

In March 2004, Syracuse University College of Law was selected by the New York State Office of Science, Technology and Academic Research (NYSTAR), in a peer reviewed state-wide competition, to be the New York State Science & Technology Law Center (NYS STLC) for the next three years. With funding in excess of $1 million, the mission of the NYS STLC is to provide legal education, research, information and support services to the more than 30 research centers supported by New York State. Professor Hagelin will serve as director of the NYS-STLC.

Ted Hagelin received his B.S. in Economics from the University of Pennsylvania, Wharton School. He received his J.D. from Temple University and his LL.M. from Harvard University.

Okay, let's go back now and quickly look at - we consider some of these cases in light of what we have just talked about. Let's look at Merck v. Integra again. What if Integra had claimed the peptides as an assay rather than a drug? Well - if they had ...(Full transcript available to logged in subscribers.).

Register & Subscribe Login

Ted Hagelin videos

Video 1 of 26 Ted Hagelin Provides Overview of U.S. Patent System
  • Ted Hagelin - What Every Researcher Should Know About Patent Law - RPI Biotechnology Management & Entrepreneurship Seminar Series
  • 10/26/2005
  • Ted Hagelin
  • 2 min. 42 sec.
Video 2 of 26 Ted Hagelin Provides Overview of U.S. Patent System
  • Ted Hagelin - What Every Researcher Should Know About Patent Law - RPI Biotechnology Management & Entrepreneurship Seminar Series
  • 10/26/2005
  • Ted Hagelin
  • 2 min. 42 sec.
Video 3 of 26 Ted Hagelin Discusses Advent of Hatch Waxman Act Which Amended US Patent Act
  • Ted Hagelin - What Every Researcher Should Know About Patent Law - RPI Biotechnology Management & Entrepreneurship Seminar Series
  • 10/26/2005
  • Ted Hagelin
  • 2 min. 50 sec.
Video 4 of 26 Ted Hagelin Discusses Advent of Hatch Waxman Act Which Amended US Patent Act
  • Ted Hagelin - What Every Researcher Should Know About Patent Law - RPI Biotechnology Management & Entrepreneurship Seminar Series
  • 10/26/2005
  • Ted Hagelin
  • 2 min. 50 sec.
Video 5 of 26 Ted Hagelin Discusses Case Which Determined Whether Hatch Waxman Covers Medical Devices
  • Ted Hagelin - What Every Researcher Should Know About Patent Law - RPI Biotechnology Management & Entrepreneurship Seminar Series
  • 10/26/2005
  • Ted Hagelin
  • 3 min. 46 sec.
Video 6 of 26 Ted Hagelin Discusses Case Which Determined Whether Hatch Waxman Covers Medical Devices
  • Ted Hagelin - What Every Researcher Should Know About Patent Law - RPI Biotechnology Management & Entrepreneurship Seminar Series
  • 10/26/2005
  • Ted Hagelin
  • 3 min. 46 sec.
Video 7 of 26 Ted Hagelin Discusses Hatch-Waxman Act's Protection of General Research To Identify New Drugs
  • Ted Hagelin - What Every Researcher Should Know About Patent Law - RPI Biotechnology Management & Entrepreneurship Seminar Series
  • 10/26/2005
  • Ted Hagelin
  • 5 min. 8 sec.
Video 8 of 26 Ted Hagelin Discusses Hatch-Waxman Act's Protection of General Research To Identify New Drugs
  • Ted Hagelin - What Every Researcher Should Know About Patent Law - RPI Biotechnology Management & Entrepreneurship Seminar Series
  • 10/26/2005
  • Ted Hagelin
  • 5 min. 8 sec.
Video 9 of 26 Ted Hagelin Discusses Difficulty in Exemptions Related To Research Tools
  • Ted Hagelin - What Every Researcher Should Know About Patent Law - RPI Biotechnology Management & Entrepreneurship Seminar Series
  • 10/26/2005
  • Ted Hagelin
  • 4 min. 14 sec.
Video 10 of 26 Ted Hagelin Discusses Difficulty in Exemptions Related To Research Tools
  • Ted Hagelin - What Every Researcher Should Know About Patent Law - RPI Biotechnology Management & Entrepreneurship Seminar Series
  • 10/26/2005
  • Ted Hagelin
  • 4 min. 14 sec.
Video 11 of 26 Ted Hagelin Shares Reevaluation of Cases When Research Tools Are Seen As Assays Instead of Drugs
  • Ted Hagelin - What Every Researcher Should Know About Patent Law - RPI Biotechnology Management & Entrepreneurship Seminar Series
  • 10/26/2005
  • Ted Hagelin
  • 2 min. 59 sec.
Video 12 of 26 Ted Hagelin Shares Reevaluation of Cases When Research Tools Are Seen As Assays Instead of Drugs
  • Ted Hagelin - What Every Researcher Should Know About Patent Law - RPI Biotechnology Management & Entrepreneurship Seminar Series
  • 10/26/2005
  • Ted Hagelin
  • 2 min. 59 sec.
Video 13 of 26 Ted Hagelin Discusses Need For Licensing If Patented Material Is Part of New Product
  • Ted Hagelin - What Every Researcher Should Know About Patent Law - RPI Biotechnology Management & Entrepreneurship Seminar Series
  • 10/26/2005
  • Ted Hagelin
  • 2 min. 17 sec.
Video 14 of 26 Ted Hagelin Discusses Need For Licensing If Patented Material Is Part of New Product
  • Ted Hagelin - What Every Researcher Should Know About Patent Law - RPI Biotechnology Management & Entrepreneurship Seminar Series
  • 10/26/2005
  • Ted Hagelin
  • 2 min. 17 sec.
Video 15 of 26 Ted Hagelin Discusses Regulation of Hybrid Technologies
  • Ted Hagelin - What Every Researcher Should Know About Patent Law - RPI Biotechnology Management & Entrepreneurship Seminar Series
  • 10/26/2005
  • Ted Hagelin
  • 2 min. 9 sec.
Video 16 of 26 Ted Hagelin Discusses Regulation of Hybrid Technologies
  • Ted Hagelin - What Every Researcher Should Know About Patent Law - RPI Biotechnology Management & Entrepreneurship Seminar Series
  • 10/26/2005
  • Ted Hagelin
  • 2 min. 9 sec.
Video 17 of 26 Ted Hagelin Discusses Concept of Experimental Use Exemptions
  • Ted Hagelin - What Every Researcher Should Know About Patent Law - RPI Biotechnology Management & Entrepreneurship Seminar Series
  • 10/26/2005
  • Ted Hagelin
  • 5 min. 35 sec.
Video 18 of 26 Ted Hagelin Discusses Concept of Experimental Use Exemptions
  • Ted Hagelin - What Every Researcher Should Know About Patent Law - RPI Biotechnology Management & Entrepreneurship Seminar Series
  • 10/26/2005
  • Ted Hagelin
  • 5 min. 35 sec.
Video 19 of 26 Ted Hagelin Provides Definition of Reach Through Royalties
  • Ted Hagelin - What Every Researcher Should Know About Patent Law - RPI Biotechnology Management & Entrepreneurship Seminar Series
  • 10/26/2005
  • Ted Hagelin
  • 1 min. 36 sec.
Video 20 of 26 Ted Hagelin Provides Definition of Reach Through Royalties
  • Ted Hagelin - What Every Researcher Should Know About Patent Law - RPI Biotechnology Management & Entrepreneurship Seminar Series
  • 10/26/2005
  • Ted Hagelin
  • 1 min. 36 sec.
Video 21 of 26 Ted Hagelin Discusses Reality of Unlicensed Use of Patented Technologies At Universities
  • Ted Hagelin - What Every Researcher Should Know About Patent Law - RPI Biotechnology Management & Entrepreneurship Seminar Series
  • 10/26/2005
  • Ted Hagelin
  • 1 min. 59 sec.
Video 22 of 26 Ted Hagelin Discusses Reality of Unlicensed Use of Patented Technologies At Universities
  • Ted Hagelin - What Every Researcher Should Know About Patent Law - RPI Biotechnology Management & Entrepreneurship Seminar Series
  • 10/26/2005
  • Ted Hagelin
  • 1 min. 59 sec.
Video 23 of 26 Ted Hagelin Discusses Reluctance of Government To Put Experimental Use Exemption Into Law
  • Ted Hagelin - What Every Researcher Should Know About Patent Law - RPI Biotechnology Management & Entrepreneurship Seminar Series
  • 10/26/2005
  • Ted Hagelin
  • 1 min. 21 sec.
Video 24 of 26 Ted Hagelin Discusses Reluctance of Government To Put Experimental Use Exemption Into Law
  • Ted Hagelin - What Every Researcher Should Know About Patent Law - RPI Biotechnology Management & Entrepreneurship Seminar Series
  • 10/26/2005
  • Ted Hagelin
  • 1 min. 21 sec.
Video 25 of 26 Ted Hagelin Shares Thoughts on How Exemption Statement Should Be Used
  • Ted Hagelin - What Every Researcher Should Know About Patent Law - RPI Biotechnology Management & Entrepreneurship Seminar Series
  • 10/26/2005
  • Ted Hagelin
  • 1 min. 39 sec.
Video 26 of 26 Ted Hagelin Shares Thoughts on How Exemption Statement Should Be Used
  • Ted Hagelin - What Every Researcher Should Know About Patent Law - RPI Biotechnology Management & Entrepreneurship Seminar Series
  • 10/26/2005
  • Ted Hagelin
  • 1 min. 39 sec.